JDRF Announces New Initiative to Pave Way for Automated Insulin Delivery Systems

Friday, October 27, 2017

NEW YORK —JDRF, the leading global organization funding type 1 diabetes (T1D) research, is announcing a new initiative that will support the development of open protocols for artificial pancreas (AP) technology.

To Read More
Subscribe Sign In
Continue reading with a subscription
Subscription options